07 Jan 2001

Paspat® (Paspat® Injektionslösung i.c., skar.) - Deutschland

Updated: 07 Jan 2001

Paspat®

Asthmoide Bronchitis; allergische Rhinitis, Otitis, Sinusitis; Conjunctivitis vernalis; erhöhte Infektanfälligkeit.

Paspat® Description, Presentation and Dosage

Paspat® Description

Paspat® Drug Class Description

Kombinationen mit Mikroorganismen-haltigen Präparaten

Paspat® Drug Description

0,2 ml enth.: Autolysate von: Staphylococcus aur. Staphylococcus alb. Streptococcus virid. Streptococcus haemolyt. Diplococcus pneumon. Neisseria catarrhal. Haemophilus influenzae, Candida albic.

Paspat® Generic Name

Paspat® Injektionslösung i.c., skar.

Paspat® Presentation

Paspat® Presentation

Paspat®

Paspat® Manufacturer

Sankyo

Related Learning Zones

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Paspat® Dosage

Paspat® Adult Dosage

Glycerol, Natriumchlorid, Wasser f. Inj.-zwecke.

Paspat® Precautions, Reactions and Contraindications

Paspat® Special Precautions

Paspat® Special Precautions

Akute Infekte, chron. Organprozesse wie Hepatitis od. Nephritis, floride Endokarditis, asthmoide Zustände b. Herzmuskel- u. Herzklappenerkrankungen, schweres Asthma (kortikoidpflichtig), Raucherbronchitis, konsumierende Erkrankungen, Tuberkulose, gleichz. Therapie m. Immunsuppressiva u. weiteren Medikamenten m. immunsuppressiver Wirkung, Komb. m. anderen Immunstimulanzien, Antigengemischen od. Impfstoffen (keine ausr. Erfahr.), Autoimmunkrankheiten, Immundefekt-Syndrome wie z. B. AIDS od. Leukämie.

Paspat® Adverse Reactions

Paspat® Adverse Reactions

Kontraind. i. 1. Trim. Strenge Ind.-Stellung im 2. u. 3. Trim. Gr 5 .

Related Drugs - Allergy/Clinical Immunology

Back to top